Dear Friends:

Earlier this month, one of the coalition's medical advisers, Professor Joel Brind, president of the Breast Cancer Prevention Institute (BCPI), published a new fact sheet on BCPI's Web site.  Brind's fact sheet provides an analysis of the paper published in the British journal Lancet in March 2004 by Valerie Beral and her colleagues at Oxford.  The fact sheet was released during my speaking tour in Europe.  Nevertheless, I wish to offer some brief comments about it and share it with you in case you missed it.

Brind reveals that the Beral paper was misrepresented in the press as a complete analysis of the abortion-breast cancer (ABC) research.  However, Oxford scientists conducted their analysis only after using a "highly biased selection process" to weed out fifteen published studies reporting risk elevations.  Oxford scientists included 28 unpublished, never-peer reviewed studies in their review.  This means that most of the 52 studies analyzed by Beral et al. are unpublished and, therefore, cannot be double-checked by other scientists for accuracy.

Brind raises additional objections to the Lancet paper, one of which is the double standard used by scientists when examining the ABC link in comparison with research concerning a different risk factor for breast cancer - combination hormone replacement therapy (HRT).  As you might have expected, scientists raise the bar higher for abortion than for other risk factors for the disease.

When scientists set out to determine the risk elevation resulting from HRT use, they include the protective effect of early menopause.  Scientists recognize that the earlier a woman goes into menopause, the lower her lifetime risk is for breast cancer.  The woman who goes into early menopause is not overexposed to estrogen during monthly menstrual cycles.

Brind says that scientists properly determine HRT risk by comparing women who use HRT with women who gained the protective effect of early menopause.

However, when scientists study the ABC link, the recognized protective effect of childbearing is omitted. The earlier a woman has her first child, the more children she has, and the longer she breastfeeds, the lower her risk is.

Scientists studying the ABC link improperly compare women who've had abortions with women who didn't become pregnant.  This produces a lower risk elevation than does a comparison between women who've had an abortion and women who've gained the protective effect of childbearing.

Women are not being told there are recognized and contested breast cancer risks of abortion.  The doctor who performs an abortion increases a woman's statistical odds of developing the disease in two ways. She's not only deprived of the protective benefits of childbearing, but she's also left with an increased number of cancer-vulnerable cells in her breasts.

It is singularly remarkable that a respected journal such as the Lancet would have published this paper.  However, abortion is a doctors' industry as well as a pharmaceutical industry.  Governments help to fund cancer research and many of them are actively pursuing population control policies.   It isn't at all surprising that scientists are doing some convoluted acrobatics.

Significantly, the Oxford group's benefactors include the United Nations Population Fund and the World Health Organization.  Both have pursued population control policies, which have been abusive of women and their right to reproduce.

Spread the word to family and friends.

Sincerely,
Karen Malec
Coalition on Abortion/Breast Cancer
www.AbortionBreastCancer.com

ABORTION-BREAST CANCER NEWS HEADLINES

FACT SHEET...Abortion and Breast Cancer: re: "collaborative reanalysis of data" published in Lancet
3/25/2004

By Joel Brind, PhD
Breast Cancer Prevention Institute
http://bcpinstitute.org/beralpaperanalysis.htm

#####

The Coalition on Abortion/Breast Cancer is an international women's organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.

Your tax-deductible, credit card donation can be made at <www.AbortionBreastCancer.com>, or you can mail your payment to: the Coalition on Abortion/Breast Cancer, P.O. Box 152, Palos Heights, IL 60463.  The IRS recognizes the coalition as a 501(c)3 organization.

FOR FURTHER INFORMATION:

Coalition on Abortion/Breast Cancer
www.AbortionBreastCancer.com

Breast Cancer Prevention Institute
www.BCPInstitute.org

Polycarp Research Institute
www.Polycarp.org

The Coalition on Abortion Breast Cancer

P.O. Box 152
Palos Heights, IL 60463
Toll Free: 877.803.0102
Local Calls: 847.421.4000
response@abortionbreastcancer.com
www.abortionbreastcancer.com